Vanillylmandelic Acid (VMA) is a metabolic breakdown product of certain catecholamines, including epinephrine (adrenaline), norepinephrine (noradrenaline), and dopamine. VMA is excreted in the urine, and its measurement in a random urine sample is used in medical tests to assess the levels of these catecholamines.
A Vanillylmandelic Acid, Random Urine test measures the concentration of VMA in a urine sample collected at a random time during the day. This test is often used to help diagnose and monitor conditions related to excessive catecholamine production, such as:
→ Neuroblastoma: Neuroblastoma is a type of cancer that primarily affects children and can originate in the adrenal glands. Elevated VMA levels can be associated with neuroblastoma, and this test is often used in the diagnosis and monitoring of the disease.
→ Pheochromocytoma: Pheochromocytoma is a rare tumor that develops in the adrenal glands and can produce excessive amounts of catecholamines. Elevated VMA levels can be a sign of pheochromocytoma.
→ Paraganglioma: Paragangliomas are tumors similar to pheochromocytomas but can develop in other areas of the body, such as the head, neck, and abdomen. They can also produce elevated levels of catecholamines and VMA.
The Vanillylmandelic Acid, Random Urine test helps healthcare providers assess catecholamine metabolism and turnover in the body, which can be informative in diagnosing and monitoring these conditions. It's important to note that while an elevated VMA level can suggest the possibility of these conditions, further evaluation, including imaging studies and clinical assessment, is typically required to confirm or rule out the diagnosis.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.